Stay updated on Amcenestrant vs Physician's Choice in ER+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Amcenestrant vs Physician's Choice in ER+ Breast Cancer Clinical Trial page.

Latest updates to the Amcenestrant vs Physician's Choice in ER+ Breast Cancer Clinical Trial page
- Check7 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study content with a basic error screen (including a Home button and site footer).SummaryDifference20%

- Check57 days agoChange DetectedA funding attribution line for 2018 U.S. NIH Grant/Contract was added, and the page revision was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check78 days agoChange DetectedA new page revision label Revision: v3.6.5 was added. The previously available Plain Language Results Summary, sponsor identifiers such as Sanofi, the line Helpful Links Provided by, and the older Revision: v3.6.4 were removed.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page now shows Revision: v3.6.4, updating the displayed version from the previous release. This indicates a deployment or content update at the page level.SummaryDifference0.0%

Stay in the know with updates to Amcenestrant vs Physician's Choice in ER+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amcenestrant vs Physician's Choice in ER+ Breast Cancer Clinical Trial page.